The Patent Finder

Terms ending in 2032

Merck Sharp and Dohme LLC

Every in-force patent on Merck Sharp and Dohme LLC's record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 8,933,102Novel Pyrrolidine Derived Beta 3 Adrenergic Receptor Agonists
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 8,933,113Mineralocorticoid Receptor Antagonists
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 9,403,807Mineralocorticoid Receptor Antagonists
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 9,045,536Cell Line 3M
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 8,568,374Intrauterine System
In force
 · High confidence
N.V. OrganonIn forceHigh confidence
US 9,062,013Positive Allosteric Modulators of the Alpha 7 Nicotinic Acetylcholine Receptor and Uses Thereof
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 8,980,920Antiviral Compounds of Three Linked Aryl Moieties to Treat Diseases Such as Hepatitis C
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 9,095,583Rorgammat Inhibitors
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 9,603,838RORgammaT INHIBITORS
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 9,884,043RORgammaT INHIBITORS
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
146 more term ends in 2032 · Pro
10 of 156 patents shown. Soonest term end first, then patent number.
Pro members see all 156.
Upgrade to Pro
152 of these are in force and held by Merck Sharp and Dohme LLC.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited